Automakers Rev Their Engines For Geneva Motor Show
Marty Padgett, editorial director for Motor Authority, discusses what we should look for at the Geneva Motor Show, as well as the scandal enveloping automakers such as Volkswagen, BMW, and Daimler. The car brands are in hot water after attempting to suppress results from animal testing.
Padgett says all eyes will be on Jaguar's I-Pace electric SUV. The car is Jaguar's answer to the Tesla Model X. Padgett explains Tesla has "reset expectations."
Padgett also talks about Pal-V's flying car. The vehicle features an internal combustion engine with 100 horsepower and has a combined 310 mile range.
Padgett also breaks down the scandal involving VW, BMW, and Daimler. The brands attempted to suppress test results that subjected monkeys to hours of diesel fuel inhalation. The results didn't show the data the companies wanted. Padgett says it will take a generation for VW to recover.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
